TTK and cancer: In this way, we identified certain isoflavones that are predicted to physically interact with the human Mps1 kinase domain with good binding affinity, strongly suggesting that these molecules correspond to a chemical class of small-sized compounds that can be used as lead chemotypes to design and develop more effective Mps1 inhibitors for the treatment of cancer.